Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy.
Banerjee S, McCutchan JA, Ances BM, Deutsch R, Riggs PK, Way L, Ellis RJ.
AIDS. 2011 Jan 14;25(2):F1-6.
Related citations
Impact of atazanavir-based HAART regimen on the carotid intima-media thickness of HIV-infected persons: a comparative prospective cohort.
de Saint-Martin L, Bressollette L, Perfezou P, Bellein V, Ansart S, Vallet S, Pasquier E.
AIDS. 2010 Nov 27;24(18):2797-801.
Serum FGF21 levels are elevated in association with lipodystrophy, insulin resistance and biomarkers of liver injury in HIV-1-infected patients.
Domingo P, Gallego-Escuredo JM, Domingo JC, Gutiérrez Mdel M, Mateo MG, Fernández I, Vidal F, Giralt M, Villarroya F.
AIDS. 2010 Nov 13;24(17):2629-37.
Postprandial lipid effects of low-dose ritonavir vs. raltegravir in HIV-uninfected adults.
Samaras K, Richardson R, Carr A.
AIDS. 2010 Jul 17;24(11):1727-31.
Traditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infection.
Ford ES, Greenwald JH, Richterman AG, Rupert A, Dutcher L, Badralmaa Y, Natarajan V, Rehm C, Hadigan C, Sereti I.
AIDS. 2010 Jun 19;24(10):1509-17.
A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206.
Tungsiripat M, Kitch D, Glesby MJ, Gupta SK, Mellors JW, Moran L, Jones L, Alston-Smith B, Rooney JF, Aberg JA.
AIDS. 2010 Jul 17;24(11):1781-4.
Kidney function and the risk of cardiovascular events in HIV-1-infected patients.
George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG.
AIDS. 2010 Jan 28;24(3):387-94.
Change to atazanavir/ritonavir treatment improves lipids but not endothelial function in patients on stable antiretroviral therapy.
Murphy RL, Berzins B, Zala C, Fichtenbaum C, Dube MP, Guaraldi G, Torriani F, Belsey E, Mitchell C, Stein JH; SABAR Study Team.
AIDS. 2010 Mar 27;24(6):885-90.
Rosuvastatin versus pravastatin in dyslipidemic HIV-1-infected patients receiving protease inhibitors: a randomized trial.
Aslangul E, Assoumou L, Bittar R, Valantin MA, Kalmykova O, Peytavin G, Fiévet MH, Boccara F, Bonnefont-Rousselot D, Melchior JC, Giral P, Costagliola D.
AIDS. 2010 Jan 2;24(1):77-83.
Morphologic and metabolic abnormalities in vertically HIV-infected children and youth.
Aldrovandi GM, Lindsey JC, Jacobson DL, Zadzilka A, Sheeran E, Moye J, Borum P, Meyer WA 3rd, Hardin DS, Mulligan K; Pediatric AIDS Clinical Trials Group P1045 team.
AIDS. 2009 Mar 27;23(6):661-72.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on